Showing results (1-10 of 88) with videos related to
Sort By:
Pageof 9
World Journal of Gastroenterology|March 18, 2015
Targeted therapy in first line treatment of RAS wild type colorectal cancerVincenzo Formica, Mario RoselliIndian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|January 27, 2016
Emerging role of S-1 in gastric cancerEriseld Krasniqi, Stefania Pellicori, Vincenzo FormicaExpert Opinion on Biological Therapy|May 22, 2018
Issues and promises of bevacizumab in prostate cancer treatmentVittore Cereda, Vincenzo Formica, Mario RoselliEuropean Journal of Cancer (Oxford, England : 1990)|December 22, 2015
The 'death pace' in the CO.17 trialVincenzo Formica, Domenico Formica, Giovanni FormicaInternational Journal of Cancer|June 7, 2018
Noninferiority of three months versus six months of oxaliplatin-based adjuvant chemotherapy for resected colon cancer. How should IDEA findings affect clinical practice?Vincenzo Formica, Alberto Zaniboni, Fotios Loupakis, et al.Current Vascular Pharmacology|June 3, 2009
Thromboembolic events in patients treated with anti-angiogenic drugsPatrizia Ferroni, Vincenzo Formica, Mario Roselli, et al.Current Medicinal Chemistry|October 21, 2016
Gender Differences in Cancer-associated Venous ThromboembolismSilvia Riondino, Fiorella Guadagni, Vincenzo Formica, et al.World Journal of Gastroenterology|September 26, 2014
Immune reaction and colorectal cancer: friends or foes?Vincenzo Formica, Vittore Cereda, Antonella Nardecchia, et al.Expert Opinion on Investigational Drugs|February 5, 2014
Targeting metastatic castration-resistant prostate cancer: mechanisms of progression and novel early therapeutic approachesVittore Cereda, Vincenzo Formica, Gioia Massimiani, et al.Expert Opinion on Investigational Drugs|April 11, 2015
Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challengesVittore Cereda, Vincenzo Formica, Antonello Menghi, et al.Pageof 9